Neither CRPS Type 1 nor Type 2 is categorically worse than the other. Both types produce the same constellation of symptoms, including severe burning pain, swelling, skin color changes, and temperature differences in the affected limb. The key distinction between them is not severity but cause: Type 1 develops without a confirmed nerve injury, while Type 2 follows a specific, identifiable nerve injury. Despite this different starting point, both types can range from mild and short-lived to severe and chronic.
What Separates Type 1 From Type 2
CRPS Type 1, historically called reflex sympathetic dystrophy, develops after an illness, injury, or surgery without any detectable damage to a specific nerve. It is far more common, with an incidence rate of about 5.46 per 100,000 people per year. Fractures, sprains, and surgical procedures are typical triggers.
CRPS Type 2, previously known as causalgia, occurs when a specific nerve has been injured and that injury can be confirmed through nerve conduction testing. It is much rarer, with an incidence of roughly 0.82 per 100,000 per year. Crush injuries, lacerations, and surgeries that directly damage a nerve are the usual causes. Sometimes a person is initially diagnosed with Type 1, but later testing reveals nerve damage, and the diagnosis shifts to Type 2.
Why People Assume Type 2 Is Worse
The logic seems straightforward: if Type 2 involves confirmed nerve damage, it must be more severe. And there is a grain of truth here. When a specific nerve is injured, the pain often follows that nerve’s territory more precisely, and the neuropathic component (shooting, electric-shock sensations along the nerve path) can be prominent. Nerve conduction studies will show measurable abnormalities in Type 2 that are absent in Type 1.
But this does not automatically translate to worse outcomes. CRPS Type 1 can be just as debilitating. The condition involves dysfunction in how the nervous system processes pain signals, changes in blood flow regulation, and inflammatory responses that are largely the same regardless of type. A person with Type 1 after a wrist fracture can end up with pain and disability every bit as severe as someone with Type 2 following a nerve laceration. The symptoms overlap so heavily that the Budapest diagnostic criteria, used worldwide, apply identically to both types. In fact, research validating those criteria could not analyze the two types separately because the clinical presentations were too similar to distinguish reliably.
Symptoms Are the Same for Both Types
Both types of CRPS share the same hallmark features. The affected limb typically develops pain that is disproportionate to the original injury, often described as burning, throbbing, or stabbing. Swelling, changes in skin color (red, blue, or mottled), and temperature differences between the affected and unaffected limb are common. Many people experience abnormal sweating, changes in nail or hair growth, and stiffness or weakness in the affected area.
One feature that may differ is the distribution of pain. In Type 2, because a specific nerve is involved, the pain and sensory changes sometimes follow a more defined anatomical pattern along that nerve’s path. In Type 1, the pain can be more diffuse and harder to map onto a single nerve territory. But in practice, both types frequently spread beyond their initial location, and many clinicians find the two indistinguishable based on symptoms alone.
Prognosis Depends on Timing, Not Type
Recovery from CRPS depends far more on how early treatment begins and how the individual responds than on whether the diagnosis is Type 1 or Type 2. Prospective studies tracking CRPS patients over time have found that fewer than 20% still have significant pain one year after the condition develops. Among people who develop early signs of CRPS after an event like a fracture, the chance of full recovery is high.
The people who struggle most are those whose CRPS persists beyond that initial window. Cross-sectional studies show that patients with the longest duration of CRPS are the most likely to have ongoing pain and sensory symptoms. What researchers still cannot predict is who will recover quickly and who will develop a chronic course. That uncertainty applies equally to both types.
Early, aggressive treatment with physical therapy and pain management gives both types the best shot at resolution. The goal is to restore movement and function in the affected limb before the nervous system settles into a chronic pain pattern. Waiting too long tends to worsen outcomes regardless of the CRPS subtype.
Why the Type 1 vs. Type 2 Label Matters Less Than You Think
For decades, researchers and clinicians debated whether these two types were fundamentally different conditions or variations of the same process. The current consensus leans toward the latter. The underlying mechanisms, including abnormal inflammation, changes in how the spinal cord and brain process pain signals, and dysfunction in the nerves that control blood vessels, are present in both types. The International Association for the Study of Pain groups them under the single umbrella of CRPS, distinguished only by whether a nerve injury can be confirmed.
Treatment approaches are also largely the same. Physical and occupational therapy, graded motor imagery, mirror therapy, and various pain management strategies are used for both types. When a specific nerve injury is identified in Type 2, treatments targeting that nerve (such as nerve blocks) may be added, but the overall rehabilitation framework does not change.
If you or someone you know has been diagnosed with either type, the subtype classification matters less for day-to-day management than factors like how long symptoms have been present, how much the limb’s function has been affected, and how quickly a comprehensive treatment plan is started. The severity of CRPS is individual, not dictated by whether it carries a “1” or “2” after the name.